Everus Construction Group, Inc. (ECG) Stock Price & Analysis
Everus Construction Group, Inc. (ECG) closed at USD 97.05 on Thursday, October 22, 2026, down 8.44% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 106; the Oct 22, 2026 session ranged USD 94.12–102.16 on volume of 990,821 shares. Market capitalization is $4.95B, with a 52-week range of USD 78.14–171.58 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:26 UTC.
Also available as compact Markdown for AI agents: nexqual.com/ECG.md
Key facts (ECG)
- Last four reported quarters (through Jun 30, 2026): revenue $4.27B, net income $254M (6.0% margin), free cash flow $250M (SEC filings).
- Valuation: P/E 19.5x (avg 22.5x at the last 2 fiscal year-ends), EV/EBITDA 13.9x, net debt $97.8M.
- 1 of 80 tracked superinvestors hold ECG (13F, Q2 2026): 1 new, 0 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $451K; 1 not under a Rule 10b5-1 plan ($451K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $145K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Buy (mean 2.29 on a 1–5 scale) (7 analysts), mean target USD 176 (range 152–200).
- Total return with dividends: 1Y +10.9% vs S&P 500 +14.9%; 5Y +84.9% vs S&P 500 +80.3%.
- Next earnings: 2026-11-03, EPS estimate USD 1.34, revenue estimate $1.18B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (ECG)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.70B | $2.85B | $2.85B | $3.75B | $4.27B |
| Gross profit | $276M | $322M | $339M | $454M | — |
| Operating income | $165M | $191M | $190M | $265M | $331M |
| Net income | $125M | $137M | $143M | $202M | $254M |
| EPS (diluted) | $2.45 | $2.69 | $2.81 | $3.95 | — |
| Free cash flow | -$61.3M | $136M | $115M | $90.0M | $250M |
| Gross margin | 10.2% | 11.3% | 11.9% | 12.1% | — |
| Operating margin | 6.1% | 6.7% | 6.7% | 7.1% | 7.8% |
| Net margin | 4.6% | 4.8% | 5.0% | 5.4% | 6.0% |
| Revenue growth | — | +5.7% | -0.2% | +31.5% | — |
| Cash + short-term investments | $2.1M | $1.6M | $86.0M | $171M | — |
| Total debt | — | $169M | $296M | $282M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (ECG)
P/E 19.5x · P/S 1.2x · EV/EBITDA 13.9x · EV/Sales 1.2x · P/FCF 19.8x · P/B 6.4x · FCF yield 5.05% · Earnings yield 5.14% · Net debt $97.8M · EV $5.05B
P/E at fiscal year-ends: Dec 2025 21.7x, Dec 2024 23.4x.
Superinvestors (SEC 13F-HR, Q2 2026) (ECG)
1 of 80 tracked investors hold ECG. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Mairs & Power | Mairs & Power Funds | <0.01% | $207K | New position |
Insider sales (SEC Form 4, open-market, last ~7 months) (ECG)
0 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-08-07 | Sanderson Paul R. | VP, CLO & Corporate Secretary | 3,300 | $451K | 14.8% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Insider purchases (SEC Form 4, open-market, last ~7 months) (ECG)
1 purchase, $145K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-08-17 | Sparby David M | Director | 1,000 | $145K | 144.95 | Too little history (no open-market trades in 2023–2025) |
Analysts (ECG)
Consensus Buy (mean 2.29 on a 1–5 scale), 7 analysts; mean target USD 176 (low 152, high 200).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-21 | DA Davidson | Initiated | Buy | $168 |
| 2026-08-13 | Cantor Fitzgerald | Target lowered | Neutral | $174 → $152 |
| 2026-08-06 | Guggenheim | Target raised | Buy | $160 → $184 |
Total return (dividends reinvested) (ECG)
| 1Y (from 2025-10-23) | 5Y (from 2024-10-28) | |
|---|---|---|
| Total return | +10.9% | +84.9% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +10.9% | +36.3% |
| Volatility (annualized) | 62.4% | 54.8% |
| Max drawdown | -42.6% (May 2026→Oct 2026) | -56.2% (Jan 2025→Mar 2025) |
ECG analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.34 | $1.18 | +13.9% | $1.18B | 1 |
| Next quarter (ends Dec 2026) | $1.19 | $1.12 | +6.2% | $1.23B | 1 |
| Current fiscal year (ends Dec 2026) | $5.31 | $4.62 | +15.0% | $4.71B | 1 |
| Next fiscal year (ends Dec 2027) | $6.29 | $5.12 | +22.9% | $5.29B | 1 |
Key Statistics (as of October 23, 2026 at 09:26 UTC)
| Price | USD 97.05 |
|---|---|
| Change | ▼ 8.44% (down) |
| Previous Close | USD 106 |
| Open | USD 102.23 |
| Day Range | USD 94.12 – 102.16 |
| 52-Week Range | USD 78.14 – 171.58 |
| Volume | 990,821 shares |
| Market Cap | $4.95B |
| Exchange | NYQ |
Technical Analysis (ECG)
Nexqual's technical model rates ECG "SELL" based on 3 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 09:26 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 26.26 (oversold) |
| vs SMA50 | Below (USD 118.63) |
| MACD | -4.21 (negative) |
Analyst Ratings (ECG)
Wall Street analysts rate ECG "Buy" based on 7 analysts, with a mean price target of USD 176 (range USD 152–200), per Nexqual as of October 23, 2026 at 09:26 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 7 |
| Mean Target | USD 176 |
| High Target | USD 200 |
| Low Target | USD 152 |
| Buy / Hold / Sell | 5 / 2 / 0 |
Earnings (ECG)
| Next Earnings Date | 2026-11-03 |
|---|---|
| EPS Estimate | USD 1.34 |
| Revenue Estimate | $1.18B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.64 vs est 1.14 ▲ beat |
| 2026-03-31 | USD 1.14 vs est 0.85 ▲ beat |
| 2025-12-31 | USD 1.08 vs est 0.77 ▲ beat |
| 2025-09-30 | USD 1.11 vs est 0.62 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financials & Fundamentals (ECG)
| Total Revenue | $4.27B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +33.70% |
| Gross Margin | +13.02% |
| Operating Margin | +9.08% |
| Profit Margin | +5.96% |
| ROE | +39.53% |
| Debt / Equity | 0.47 |
| Current Ratio | 1.59 |
| Total Cash | $157.66M |
| Total Debt | $364.15M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $250.37M (5.9% of revenue) |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financial Health Score (ECG)
Nexqual rates Everus Construction Group, Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:26 UTC.
| Growth | Strong — Revenue +31% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 13%, operating 9% (last 12 months) |
| Balance Sheet | Solid — $177M cash and investments vs $274M debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $250M (last 4 quarters to Jun 2026, SEC), 6% margin |
| Efficiency | Strong — ROE 40%, ROA 11.7% |
Ownership (ECG)
| Insider Ownership | +0.34% |
|---|---|
| Institutional Ownership | +87.47% |
| Shares Outstanding | 51.04M |
| Float | 50.86M |
| Short % of Float | +5.22% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Leadership (ECG)
Everus Construction Group, Inc. is led by Jeffrey S. Thiede, President, CEO & Director, per Nexqual as of October 23, 2026 at 09:26 UTC.
| President, CEO & Director | Jeffrey S. Thiede |
|---|---|
| VP, CFO & Treasurer | Maximillian J. Marcy |
| Executive VP & COO | Thomas D. Nosbusch |
| Vice President of Corporate Development & Strategy | Timothy R. Sznewajs |
| Director of Communications | Laura Lueder |
Major Backers & Investors (ECG)
Notable institutional backers of Everus Construction Group, Inc. include SmallCap World Fund Inc, Invesco, Wasatch Advisors LP, according to Nexqual as of October 23, 2026 at 09:26 UTC.
Active Investors
| Investor | Stake |
|---|---|
| SmallCap World Fund Inc | 4.06% |
| Invesco | 3.07% |
| Wasatch Advisors LP | 2.38% |
| First TRT Exch-Trd Fd. VI-First TRT RBA American Industrial Renaissanc | 2.28% |
| Capital International Investors | 2.15% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 12.91% |
| Vanguard Group | 9.68% |
| State Street | 3.32% |
| Geode Capital | 2.85% |
| Dimensional Fund Advisors | 2.05% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KBR | KBR, Inc. | USD 39.53 | ▲ 5.95% |
| ROAD | Construction Partners, Inc. | USD 83.93 | ▼ 1.19% |
| GVA | Granite Construction Incorporat | USD 107.45 | ▼ 2.08% |
| AGX | Argan, Inc. | USD 330.3 | ▼ 4.5% |
| FLR | Fluor Corporation | USD 43.42 | ▼ 6.44% |
| DY | Dycom Industries, Inc. | USD 225.16 | ▼ 5.18% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:26 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt